Document is current
Any future updates will be listed below
-
Authors
Munoz-Moreno, Raquel https://orcid.org/0000-0002-4521-0488
Allaj, Viola
Gadee, Eddie
Button, Julie M.
Diaz, Fernando
Maddur, Mohan S.
Chen, Wei
Hu, Cheng Hui
Martinez, Lyndsey
Giannakou, Andreas
Campbell, Adam Lee
Miteva, Yana
Guo, Pengbo
Huang, Bridget
Shi, Shuai
Lotvin, Jason
Tompkins, Kristin
Allen, Pirada Suphaphiphat
Solórzano, Alicia https://orcid.org/0000-0003-0072-3463
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 21 February 2025
First Online: 14 March 2025
Competing interests
: The study was funded by Pfizer Inc. Pfizer was involved in the design, analysis, and interpretation of the data in this research study, the writing of this report, and the decision to publish. The results in this manuscript are part of a collaboration between BioNTech and Pfizer. All authors are current or former employees of Pfizer Inc., and may, consequently, be shareholders. F.D., R.M.M., A.S. and P.S.A. are listed as inventors on a patent application related to nucleoside-modified RNA LNP vaccines encoding varicella zoster virus.
